Vietnam Head and Neck Cancer Therapeutics Market Report 2023 to 2030

Vietnam Head and Neck Cancer Therapeutics Market Analysis

$ 3999

The Vietnam Head and Neck Cancer Therapeutics Market was valued at $3.42 Mn in 2023 and is predicted to grow at a CAGR of 14% from 2023 to 2030, to $8.55 Mn by 2030. The key drivers of this industry include rising incidence, aging population, and rising disposable income. The industry is primarily dominated by players such as Merck, Pfizer, Novartis, and AstraZeneca among others.

ID: IN10VNPH577 CATEGORY: Pharmaceuticals GEOGRAPHY: Vietnam AUTHOR: Aashwi Mehta

Buy Now

Vietnam Head and Neck Cancer Therapeutics Market Executive Summary

The Vietnam Head and Neck Cancer Therapeutics Market was valued at $3.42 Mn in 2023 and is predicted to grow at a CAGR of 14% from 2023 to 2030, to $8.55 Mn by 2030.

Head and neck cancer sites include the squamous cells lining the mucosal surfaces of the head and neck—such as those within the mouth, throat, and larynx (voice box). Salivary glands, sinuses, muscles, or nerves in these regions can also serve as the initial sites for head and neck malignancies. Usage of alcohol and tobacco products, as well as HPV infection, are common risk factors. A painful lump in the neck, a persistent mouth or throat ulcer, difficulty swallowing, and a change in voice that sounds hoarse are all possible signs of head and neck cancer.

By 2030, there is a 30% yearly increase expected in the overall incidence of Head and Neck Cancer (HNC). According to estimates, there are more than 20 cases of HNC per 100,000 men, two to four times as many as women. Oral and lip cancer is the second most prevalent cancer in men in developing countries (10 per 100,000). All populations have an increased risk of HNC with age, and most instances are diagnosed in people over 50. The market is driven by significant factors like rising incidence, aging population, and rising disposable income. However, inadequate infrastructure, lack of awareness, and shortage of workers restrict the growth and potential of the market.

Prominent players in this field include Merck, Pfizer, Novartis, and AstraZeneca among others.

Vietnam Head and Neck Cancer Therapeutics Market Report 2023 to 2030

Market Dynamics

Market Growth Drivers

Rising Incidence: The head and neck cancer therapy market is significantly driven by the increasing incidence of the disease due to risk factors such as tobacco use, and alcohol consumption. As a result of the increasing prevalence of cancer, Vietnam's healthcare system is facing an increased need for novel medicines and medical solutions to meet the growing burden.

Aging Population: The substantial demographic shift towards rapid aging in Vietnam, with individuals aged 60 and older predicted to exceed 25% of the population by 2050, is a significant driver for the head and neck cancer therapeutics market. This transition towards an aged society by 2036 highlights the increasing healthcare needs of the elderly population, including the demand for effective therapeutic interventions for conditions such as head and neck cancer.

Rising Disposable Income: The forecasted increase in disposable income among Vietnam's middle class, with an expected rise in households earning over $5,000 annually by 2027, serves as a significant driver for the head and neck cancer therapeutics market. This rise in disposable income directly impacts healthcare affordability, allowing more individuals access to advanced cancer treatments, including therapies for head and neck cancers, contributing to the advancement of the HNC therapeutic market.

Market Restraints

Inadequate Infrastructure: The limited allocation of resources to healthcare infrastructure, equipment, and staff training poses a significant restraint for the head and neck cancer therapeutics market in Vietnam. These constraints hinder the timely and effective delivery of therapeutic interventions, impacting patient outcomes and limiting the growth potential of the therapeutic market in Vietnam for head and neck cancer.

Lack of Awareness: The head and neck cancer market in Vietnam is constrained by a lack of public knowledge about the disease and its early detection methods. Uncertainty about the warning signs, symptoms, and risk factors of head and neck cancers can cause delays in diagnosis and loss of opportunities for early-stage intervention therapy.

Shortage of Workers: Insufficient availability of healthcare professionals, especially in isolated and hilly areas like the North West, Central Highland, and Mekong Delta, can lead to delayed diagnosis, insufficient treatment alternatives, and diminished quality of care for patients with head and neck cancer. This shortage impacts patient outcomes and leads to overall market restrictions in Vietnam's head and neck cancer therapeutic sector by hindering the efficient delivery of therapeutic interventions.

Regulatory Landscape and Reimbursement Scenario

The national regulatory agency and competent authority for healthcare in Vietnam is the Ministry of Health (MoH). The Drug Administration of Vietnam (DAV) is the regulatory body that approves drugs in Vietnam. It is managed by the MoH and is in charge of the nation's drug approval procedure. Social Health Insurance (SHI) is compulsory health coverage for the majority of Vietnamese citizens, providing partial financial support for cancer treatment expenses.

Competitive Landscape

Key Players

Here are some of the major key players in the Vietnam Head and Neck Cancer Therapeutic Market:

Merck
Pfizer
AstraZeneca
Novartis
Eli Lilly and Company
GlaxoSmithKline
Sanofi
Roche
AbbVie
Takeda Pharmaceutical Company Limited

1. Executive Summary
1.1 Disease Overview
1.2 Global Scenario
1.3 Country Overview
1.4 Healthcare Scenario in Country
1.5 Patient Journey
1.6 Health Insurance Coverage in Country
1.7 Active Pharmaceutical Ingredient (API)
1.8 Recent Developments in the Country

2. Market Size and Forecasting
2.1 Epidemiology of Disease
2.2 Market Size (With Excel & Methodology)
2.3 Market Segmentation (Check all Segments in Segmentation Section)

3. Market Dynamics
3.1 Market Drivers
3.2 Market Restraints

4. Competitive Landscape
4.1 Major Market Share

4.2 Key Company Profile (Check all Companies in the Summary Section)

4.2.1 Company
4.2.1.1 Overview
4.2.1.2 Product Applications and Services
4.2.1.3 Recent Developments
4.2.1.4 Partnerships Ecosystem
4.2.1.5 Financials (Based on Availability)

5. Reimbursement Scenario
5.1 Reimbursement Regulation
5.2 Reimbursement Process for Diagnosis
5.3 Reimbursement Process for Treatment

6. Methodology and Scope

Vietnam Head and Neck Cancer Therapeutics Market Segmentation

By Treatment

Targeted Therapy
Immunotherapy
Radiation Therapy
Surgeries

By End Users

Hospitals
Specialty Centers
Ambulatory Surgical Centers

By Distribution Channel

Hospital-based pharmacies
Retail pharmacies
Online pharmacies

By Route of administration

Injectable
Oral

Methodology for Database Creation

Our database offers a comprehensive list of healthcare centers, meticulously curated to provide detailed information on a wide range of specialties and services. It includes top-tier hospitals, clinics, and diagnostic facilities across 30 countries and 24 specialties, ensuring users can find the healthcare services they need.

Additionally, we provide a comprehensive list of Key Opinion Leaders (KOLs) based on your requirements. Our curated list captures various crucial aspects of the KOLs, offering more than just general information. Whether you're looking to boost brand awareness, drive engagement, or launch a new product, our extensive list of KOLs ensures you have the right experts by your side. Covering 30 countries and 36 specialties, our database guarantees access to the best KOLs in the healthcare industry, supporting strategic decisions and enhancing your initiatives.

How Do We Get It?

Our database is created and maintained through a combination of secondary and primary research methodologies.

1. Secondary Research

With many years of experience in the healthcare field, we have our own rich proprietary data from various past projects. This historical data serves as the foundation for our database. Our continuous process of gathering data involves:

Analyzing historical proprietary data collected from multiple projects.
Regularly updating our existing data sets with new findings and trends.
Ensuring data consistency and accuracy through rigorous validation processes.

With extensive experience in the field, we have developed a proprietary GenAI-based technology that is uniquely tailored to our organization. This advanced technology enables us to scan a wide array of relevant information sources across the internet. Our data-gathering process includes:

Searching through academic conferences, published research, citations, and social media platforms
Collecting and compiling diverse data to build a comprehensive and detailed database
Continuously updating our database with new information to ensure its relevance and accuracy

2. Primary Research

To complement and validate our secondary data, we engage in primary research through local tie-ups and partnerships. This process involves:

Collaborating with local healthcare providers, hospitals, and clinics to gather real-time data.
Conducting surveys, interviews, and field studies to collect fresh data directly from the source.
Continuously refreshing our database to ensure that the information remains current and reliable.
Validating secondary data through cross-referencing with primary data to ensure accuracy and relevance.

Combining Secondary and Primary Research

By integrating both secondary and primary research methodologies, we ensure that our database is comprehensive, accurate, and up-to-date. The combined process involves:

Merging historical data from secondary research with real-time data from primary research.
Conducting thorough data validation and cleansing to remove inconsistencies and errors.
Organizing data into a structured format that is easily accessible and usable for various applications.
Continuously monitoring and updating the database to reflect the latest developments and trends in the healthcare field.

Through this meticulous process, we create a final database tailored to each region and domain within the healthcare industry. This approach ensures that our clients receive reliable and relevant data, empowering them to make informed decisions and drive innovation in their respective fields.